| Product NDC: | 55390-122 |
| Proprietary Name: | Cyclosporine |
| Non Proprietary Name: | Cyclosporine |
| Active Ingredient(s): | 50 mg/mL & nbsp; Cyclosporine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-122 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065004 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19991215 |
| Package NDC: | 55390-122-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-122-10) > 5 mL in 1 VIAL |
| NDC Code | 55390-122-10 |
| Proprietary Name | Cyclosporine |
| Package Description | 10 VIAL in 1 BOX (55390-122-10) > 5 mL in 1 VIAL |
| Product NDC | 55390-122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyclosporine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19991215 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | CYCLOSPORINE |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |